On Dec. 22, AK Steel (NYSE:AKS) said that it plans to release its fourth quarter and full-year 2014 financial results before the opening of trading on the New York Stock Exchange on Tuesday, January 27, 2015. AK Steel Holding Corporation (NYSE:AKS) in last trading activity advanced 0.51% to close at $5.97. Company weekly performance is 3.65% while its quarterly performance stands at -21.76%. AK Steel Holding Corporation (NYSE:AKS) is -47.49% away from its 52 week high.
Shares of eBay (NASDAQ:EBAY) were the target of a large drop in short interest during the month of December. As of December 15th, there was short interest totalling 17,262,801 shares, a drop of 11.2% from the November 28th total of 19,446,243 shares, Analyst RN reports. On last trading day eBay Inc. (NASDAQ:EBAY) advanced 0.16% to close at $56.21. Its volatility for the week is 1.37% while volatility for the month is 1.54%. EBAY’s sales growth for past 5 years was 13.40% and its EPS growth for past 5 years was 9.90%. eBay Inc. (NASDAQ:EBAY) monthly performance is 2.16%.
Oil States International, Inc. (NYSE:OIS) announced that its subsidiary, Oil States Industries, Inc., has acquired Montgomery Machine Company, Inc. (“MMC”). Headquartered in Houston, Texas, MMC combines machining and proprietary cladding technology and services to manufacture high-specification components for the offshore capital equipment industry on a global basis. Terms of the transaction were not disclosed. Oil States International Inc. (NYSE:OIS) has 1.10% insider ownership while its institutional ownership stands at 89.60%. In last trading activity company’s stock closed at $48.64.
Rouse Properties (NYSE:RSE) Director Michael M. Mullen bought 5,000 shares of the company’s stock in a transaction dated Monday, December 8th. The stock was purchased at an average cost of $18.12 per share, with a total value of $90,600.00. On Friday shares of Rouse Properties, Inc. (NYSE:RSE) closed at $18.65. Company’s sales growth for last 5 years was -4.60% and EPS growth for next 5 years is recorded as 6.10%.
On Dec 30, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) received good news when the FDA approved its supplemental new drug application for its cystic fibrosis (CF) drug Kalydeco. On last trading day Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) advanced 3.59% to close at $123.07. Its volatility for the week is 2.85% while volatility for the month is 3.92%. VRTX’s sales growth for past 5 years was 47.20% and its EPS growth for past 5 years was 9.50%. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) monthly performance is 3.46%.